Not as much as science, clinical progress (P3), academic collaborators, medical research institutions eager to use Pluristem's products, massive patent position, products that target huge patient populations.... etc.
"Leadership Matters!" - yeah, and how would you know that Pluristem lacks leadership. Their accomplishment to date is pretty impressive.